52
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Impact of new Joint British Societies’ (JBS 2) guidelines on prevention of cardiovascular disease: evaluation of serum total cholesterol goal achievement in UK clinical practice

, , &
Pages 2027-2034 | Accepted 19 Jun 2007, Published online: 19 Jul 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Gillian C. Hall, Vian Amber, Chris O’Regan & Kevin Jameson. (2013) Observational study of ezetimibe discontinuation in primary care practices in the UK. Current Medical Research and Opinion 29:12, pages 1737-1745.
Read now
Kittipan Rerkasem, Patrick J Gallagher, Robert F Grimble, Philip C Calder & Clifford P Shearman. (2008) Managing hypercholesterolemia and its correlation with carotid plaque morphology in patients undergoing carotid endarterectomy. Vascular Health and Risk Management 4:6, pages 1259-1264.
Read now

Articles from other publishers (4)

John Reckless, Glenn Davies, Kaan Tunceli, X. Henry Hu & Philippe Brudi. (2010) Projected Cost-Effectiveness of Ezetimibe/Simvastatin Compared with Doubling the Statin Dose in the United Kingdom: Findings from the INFORCE Study. Value in Health 13:6, pages 726-734.
Crossref
S. Shah, R. Ceska, B. Gil-Extremera, J. F. Paolini, H. Giezek, K. Vandormael, A. Mao, C. McCrary Sisk & D. Maccubbin. (2010) Efficacy and safety of extended-release niacin/laropiprant plus statin vs. doubling the dose of statin in patients with primary hypercholesterolaemia or mixed dyslipidaemia. International Journal of Clinical Practice 64:6, pages 727-738.
Crossref
Lily P.H. Yang & Gillian M. Keating. (2009) Fenofibric Acid. American Journal Cardiovascular Drugs 9:6, pages 401-409.
Crossref
Adam P. Levine, Dimitri P. MikhailidisTessa Moross, Karen Benson & Mayur Gor. (2008) Achieving Vascular Risk Factor Targets: A Survey of a London General Practice. Angiology 59:1, pages 36-46.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.